Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quantum BioPharma Ltd
C.QNTM
Alternate Symbol(s):
QNTM
Healthcare
Quantum BioPharma Ltd, formerly FSD Pharma Inc., is a biotechnology company. It operates in two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of its two primary drug candidates, consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. Its Strategic Investments segment is focused on...
generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:QNTM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(83)
•••
Bigmac4000
X
View Profile
View Bullboard History
Comment by
Bigmac4000
on Aug 14, 2024 8:42pm
RE:Financials out...Everyone but the Retail taken care of
More than 3 million wasted between investors relations (money to friends ) and consulting fees (money to friends). Imagine it they used 3+ million to buy back shares before the RS. At $0.10 per share
...more
(91)
•••
doggy123
X
View Profile
View Bullboard History
Comment by
doggy123
on Aug 14, 2024 7:40pm
RE:Financials out...Everyone but the Retail taken care of
Junky junk company
(23)
•••
JAKPUG4LIFE
X
View Profile
View Bullboard History
Post by
JAKPUG4LIFE
on Aug 14, 2024 10:27am
Financials out...Everyone but the Retail taken care of
Current assets Cash and cash equivalents 3,306,641 June 30, 2024 Professional fees Professional fees were $958,377 and $1,816,800 for the three and six months ended June 30, 2024
...more
(83)
•••
Bigmac4000
X
View Profile
View Bullboard History
Comment by
Bigmac4000
on Aug 13, 2024 7:49pm
RE:RE:Tuesday Math
To carry on from where Jak left off. You must be high kg you think investors won't care that this company has blown over 100 million, 2 reverse splits in a few years and over a dozen failed
...more
(23)
•••
JAKPUG4LIFE
X
View Profile
View Bullboard History
Post by
JAKPUG4LIFE
on Aug 13, 2024 1:52pm
RE:Tuesday Math
What a thoughtless comment, New Investors should care, same thing will happen as it's happened in the past. Are you one of the $30,000 pr guys getting paid for posting these bloated and mis
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 13, 2024 11:32am
RE:Tuesday Math
You're living in the past. New investors don't care.
(83)
•••
Bigmac4000
X
View Profile
View Bullboard History
Post by
Bigmac4000
on Aug 13, 2024 11:00am
Tuesday Math
65-1 at current rate USD = $6.50 But it looks better in CAN = $ 9.10 Two more days. Kiss your shares goodbye. Can we make wagers on how soon they start giving shares away as bonuses again. From
...more
(83)
•••
Bigmac4000
X
View Profile
View Bullboard History
Post by
Bigmac4000
on Aug 12, 2024 10:34am
Monday math
So at $0.18 cents and a 65-1 RS would value each share at $11.70. Sounds great. But for most to recover their original share price this will have to climb to between $600 & $900 depending
...more
(83)
•••
Bigmac4000
X
View Profile
View Bullboard History
Comment by
Bigmac4000
on Aug 11, 2024 4:40pm
RE:RE:New Press Release - Goldman Small Cap Research Publishes New Research Report on FSD Pharma, Inc.
Ok so you just posted a complete false lie. Sales in 2023? Wait lol what?! Please what sales did they have in 2023? It's 7 months into 2024. Not a product to be seen. Where do you
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 11, 2024 12:37pm
RE:RE:Up 200% today
From filing statement: UNBUZZD planned pricing is 12 oz slim can retail pricing $4.99 each, 4 packs at $19.99, 12 packs at $54.99. Pricing on Powder Sticks at $3.99, 2-pack $7.99, 8 packs at
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 11, 2024 12:34pm
$6 US tp
Unbuzzd™: It is challenging to value Unbuzzd™ given the limited number of similar publicly traded companies. In our comparable company analysis, we screened for companies in the alcohol hangover
...more
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 11, 2024 12:11pm
RE:RE:New Press Release - Goldman Small Cap Research Publishes New Research Report on FSD Pharma, Inc.
HUGE expects to receive a 7% royalty on UNBUZZD sales up to $250 million and then 3% from that point forward, with FSD retaining a 25% stake in Celly Nu until it reaches a $1 Billion market cap.
(2233)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Aug 11, 2024 12:08pm
RE:New Press Release - Goldman Small Cap Research Publishes New Research Report on FSD Pharma, Inc.
Goldman remarked, "Our forecasts assume full product sales of UNBUZZD™ will grow from $42M in 2023 to $138.7M in 2025, from which HUGE is entitled to royalties.
(29)
•••
opsd1
X
View Profile
View Bullboard History
Post by
opsd1
on Aug 11, 2024 10:23am
FSD Pharma (HUGE) Rockets 225%
https://www.bovnews.com/2024/08/09/fsd-pharma-huge-rockets-225-on-launch-of-innovative-hangover-recovery-drink/ Conclusion FSD Pharma Inc.’s substantial stock increase reflects the market’s
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >